Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Will I need to pass a federal background investigation
[Greger then walks through the package inserts for Wegovy (high-dose semaglutide) and Zepbound (tirzepatide), listing thyroid-tumour warnings, pancreatitis, gall-bladder disease, risk of hypoglycaemia when combined with other agents, kidney injury, allergic reactions, diabetic retinopathy worsening, raised heart-rate, and suicidal thoughts or behaviours.] Suicide risk (the good news segment)
The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board
Fee will be deducted if you sign-up for the in-office or at-home plan
until then, the compound remains a subject of laboratory investigation, supplied strictly for research use only
US$ 24.68
US$ 25.78
US$ 27.90
